Floatz logo

2-ACETYLFURO-1,4-NAPHTHOQUINONE

Colorectal Cancer

Takayuki YoshinoSmall moleculePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
59/ 100

Competitive context

840 Active assets in the Colorectal Cancer cohort.

Asset / SponsorPhaseRating
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
MARBLE DUST
James Varani
Phase 2/3BB
PANITUMUMAB
M.D. Anderson Cancer Center
Phase 3BB
Cetuximab
Shanghai Henlius Biotech
Phase 4BB
FLUOROURACILUM
Washington University School of Medicine
Phase 4BB

View all 50 →

Same molecule, other indications

2-ACETYLFURO-1,4-NAPHTHOQUINONE is also rated in:

pancreatic ductal adenocarcinomaDormant
B
Indicative ·
62 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
61 / 100
View asset →
Previously Treated Metastatic Colorectal CancerDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →